Search Results - "Delaidelli, Alberto"

Recent Advances in the Diagnosis and Treatment of Brain Tumors.

Authors: Delaidelli, Alberto Moiraghi, Alessandro

Source: Brain Sciences (2076-3425). Mar2024, Vol. 14 Issue 3, p224. 5p.

Pediatric Brain Tumours: Lessons from the Immune Microenvironment.

Authors: Yao, Betty Delaidelli, Alberto Vogel, Hannes et al.

Source: Current Oncology. May2023, Vol. 30 Issue 5, p5024-5046. 23p. 1 Diagram, 2 Charts.

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.

Authors: Delaidelli, Alberto Richner, Mette Jiang, Lixiang et al.

Source: Acta Neuropathologica Communications. Dec2021, Vol. 9 Issue 1, p1-16. 16p.

RNA modifications in brain tumorigenesis.

Authors: Huang, Albert Z. Delaidelli, Alberto Sorensen, Poul H.

Source: Acta Neuropathologica Communications. 5/6/2020, Vol. 8 Issue 1, p1-13. 13p.

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma.

Authors: Hai-Feng Zhang Delaidelli, Alberto Javed, Sumreen et al.

Source: Science Advances. 8/25/2023, Vol. 9 Issue 34, p1-17. 17p.

Actions speak louder than ORFs: A non-canonical microprotein promotes medulloblastoma oncogenesis.

Authors: Delaidelli, Alberto Oliveira de Santis, Jessica Sorensen, Poul H.

Source: Molecular Cell. Jan2024, Vol. 84 Issue 2, p188-190. 3p.

Isolated subarachnoid hemorrhage in mild traumatic brain injury: is a repeat CT scan necessary? A single-institution retrospective study.

Authors: Guatta, Ramona Delaidelli, Alberto May, Adrien Thomas et al.

Source: Acta Neurochirurgica. Nov2021, Vol. 163 Issue 11, p3209-3216. 8p.

Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.

Authors: Lim, Jonathan K. M. Delaidelli, Alberto Minaker, Sean W. et al.

Source: Proceedings of the National Academy of Sciences of the United States of America. 5/7/2019, Vol. 116 Issue 19, p9433-9442. 10p.

Subjects: Cystine, Glutamic acid, Intracellular pathogens, Oxidation-reduction reaction, Pathogenic microorganisms

Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.

Authors: Nabbi, Arash Beck, Pengbo Delaidelli, Alberto et al.

Source: Genome Medicine. 9/7/2023, Vol. 15 Issue 1, p1-24. 24p.

Translational control in brain pathologies: biological significance and therapeutic opportunities.

Authors: Delaidelli, Alberto Sorensen, Poul H. Jan, Asad et al.

Source: Acta Neuropathologica. Apr2019, Vol. 137 Issue 4, p535-555. 21p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Neurological Outcome of Spinal Hemangioblastomas: An International Observational Multicenter Study About 35 Surgical Cases.

Authors: Alsereihi, Motaz Creatura, Donato D'Onofrio, Ginevra F. et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1428. 23p.

eEF2K protects MYCN -amplified cells from starvation.

Authors: Delaidelli, Alberto Leprivier, Gabriel Sorensen, Poul H.

Source: Cell Cycle. 2017, Vol. 16 Issue 18, p1633-1634. 2p.

This result is not displayed to guests.
Login for full access.

Craniocervical fractures management in case of craniocervical pneumatization: case report and review of the literature.

Authors: Jannelli, Gianpaolo Moiraghi, Alessandro Delaidelli, Alberto et al.

Source: Acta Neurochirurgica. Aug2021, Vol. 163 Issue 8, p2279-2288. 10p.

Surgical Treatment of Spinal Meningiomas in the Elderly (≥75 Years): Which Factors Affect the Neurological Outcome? An International Multicentric Study of 72 Cases.

Authors: Capo, Gabriele Moiraghi, Alessandro Baro, Valentina et al.

Source: Cancers. Oct2022, Vol. 14 Issue 19, p4790. 15p.

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.

Authors: Hamilton, Amber K. Radaoui, Alexander B. Tsang, Matthew et al.

Source: Cancer Cell. Nov2024, Vol. 42 Issue 11, p1970-19198. 17229p.

eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response.

Authors: Jan, Asad Jansonius, Brandon Delaidelli, Alberto et al.

Source: Acta Neuropathologica. Jan2017, Vol. 133 Issue 1, p101-119. 19p.

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.

Authors: Jan, Asad Jansonius, Brandon Delaidelli, Alberto et al.

Source: Acta Neuropathologica Communications. 7/2/2018, Vol. 6 Issue 1, pN.PAG-N.PAG. 1p.